Konstantin Fiedler Sells 358 Shares of Foundation Medicine Inc (FMI) Stock

Foundation Medicine Inc (NASDAQ:FMI) COO Konstantin Fiedler sold 358 shares of the firm’s stock in a transaction dated Monday, April 2nd. The shares were sold at an average price of $74.88, for a total transaction of $26,807.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of NASDAQ:FMI opened at $72.25 on Friday. Foundation Medicine Inc has a twelve month low of $29.90 and a twelve month high of $87.10. The company has a current ratio of 1.86, a quick ratio of 1.67 and a debt-to-equity ratio of 1.90.

How to Become a New Pot Stock Millionaire

Foundation Medicine (NASDAQ:FMI) last released its earnings results on Wednesday, March 7th. The company reported ($1.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.97) by ($0.08). Foundation Medicine had a negative return on equity of 207.73% and a negative net margin of 105.60%. The firm had revenue of $48.90 million for the quarter, compared to the consensus estimate of $48.69 million. During the same quarter in the previous year, the business posted ($1.02) EPS. Foundation Medicine’s revenue was up 69.8% on a year-over-year basis. sell-side analysts predict that Foundation Medicine Inc will post -4.22 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Chevy Chase Trust Holdings Inc. raised its stake in Foundation Medicine by 0.9% during the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 1,068,293 shares of the company’s stock worth $72,825,000 after acquiring an additional 9,152 shares during the period. Discovery Group I LLC raised its stake in Foundation Medicine by 0.9% during the 3rd quarter. Discovery Group I LLC now owns 836,986 shares of the company’s stock worth $33,647,000 after acquiring an additional 7,181 shares during the period. Boston Advisors LLC bought a new stake in Foundation Medicine during the 4th quarter worth approximately $13,000,000. Geode Capital Management LLC raised its stake in Foundation Medicine by 12.8% during the 4th quarter. Geode Capital Management LLC now owns 161,420 shares of the company’s stock worth $11,008,000 after acquiring an additional 18,289 shares during the period. Finally, Advisory Research Inc. raised its stake in Foundation Medicine by 172.2% during the 4th quarter. Advisory Research Inc. now owns 76,581 shares of the company’s stock worth $5,223,000 after acquiring an additional 48,450 shares during the period. Institutional investors own 31.17% of the company’s stock.

FMI has been the topic of a number of recent analyst reports. Cowen initiated coverage on shares of Foundation Medicine in a report on Thursday, February 15th. They set an “outperform” rating and a $90.00 price target on the stock. Goldman Sachs initiated coverage on shares of Foundation Medicine in a research note on Monday, January 29th. They issued a “neutral” rating and a $73.00 price objective on the stock. Zacks Investment Research cut shares of Foundation Medicine from a “buy” rating to a “sell” rating in a research note on Wednesday, January 3rd. BidaskClub upgraded shares of Foundation Medicine from a “hold” rating to a “buy” rating in a research note on Wednesday, December 27th. Finally, Wells Fargo reiterated a “market perform” rating and issued a $80.00 price objective (up previously from $67.00) on shares of Foundation Medicine in a research note on Thursday, March 8th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $69.60.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3334609/konstantin-fiedler-sells-358-shares-of-foundation-medicine-inc-fmi-stock.html.

Foundation Medicine Company Profile

Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.

Insider Buying and Selling by Quarter for Foundation Medicine (NASDAQ:FMI)

Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

FuturXe  Trading 25.4% Lower  This Week
FuturXe Trading 25.4% Lower This Week
Analysts Anticipate McDermott International  Will Announce Earnings of $0.05 Per Share
Analysts Anticipate McDermott International Will Announce Earnings of $0.05 Per Share
Analysts Expect Gladstone Commercial Co.  to Post $0.40 EPS
Analysts Expect Gladstone Commercial Co. to Post $0.40 EPS
EuropeCoin  Achieves Market Capitalization of $5.98 Million
EuropeCoin Achieves Market Capitalization of $5.98 Million
Sentinel Chain Trading Up 45.9% This Week
Sentinel Chain Trading Up 45.9% This Week
CHIPS Price Up 2.8% Over Last Week
CHIPS Price Up 2.8% Over Last Week


© 2006-2018 Ticker Report. Google+.